Insider filing · BSX
Daniel J. Brennan
EVP and CFO
profile →
Boston Scientific Corporation
BSX · Healthcare · 79 filings in 24 months
ticker →
Daniel J. Brennan sold $1.6M of Boston Scientific (BSX)
Executed Feb 12 2025, disclosed Feb 13 2025, 1 day later.
Value, as filed
$1.6M
15,087 sh × $105.07
Executed
Feb 12 2025
the trade date, as filed
Disclosed
Feb 13 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DBDaniel J. Brennan (EVP and CFO) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $8.9M of BSX (84,863 sh across 3 lots, as filed), executed Feb 18 2025.
The name
BSXHealthcare · Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties wor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Daniel J. Brennan in BSX
BSXSALE
Boston Scientific Corporation
$8.9M84,863 sh across 3 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $871K
9,689 sh × $89.86
Exec Jan 3 2025
Filed Jan 3 2025 · 5:30 PM ET